FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved CD20xCD3 bispecific Lunsumio VELO™ ...
The Manila Times

Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML

CR in newly diagnosed NPM1-m AML, with 68% (17/25) of CRc responders achieving molecular MRD negativity by central NGS ...
IGN

The Forge Reroll Guide – How to Change Class, Unlock New Races, and Get More Rerolls

Changing your class in The Forge isn’t as simple as picking the one you want — it all comes down to rerolls and luck. In this guide, we break down every method you can use to reroll your race so you ...
Men's Health

Sprint Interval Training Delivers Major Fitness Gains in Minimal Time – Here’s Why It Works

SIT may sound laid-back, but it’s anything but. Short for sprint interval training, it’s a form of high-intensity exercise that has nothing to do with taking a breather. Running is the obvious choice ...